NKG2D is an activating receptor for NK, NKT, CD8+, and γδ+ T effector cells, and down-regulation of NKG2D in HNSCC patients seems to be a crucial mechanism of immune evasion. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.